Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$277K Hold
764
0.05% 195
2026
Q1
$269K Sell
764
-169
-18% -$60.2K 0.05% 198
2025
Q4
$305K Hold
933
0.05% 179
2025
Q3
$263K Hold
933
0.05% 208
2025
Q2
$261K Hold
933
0.05% 197
2025
Q1
$291K Sell
933
-343
-27% -$101K 0.06% 175
2024
Q4
$333K Buy
1,276
+500
+64% +$148K 0.07% 159
2024
Q3
$250K Sell
776
-8
-1% -$2.62K 0.06% 199
2024
Q2
$245K Buy
784
+8
+1% +$2.35K 0.06% 202
2024
Q1
$221K Hold
776
0.05% 221
2023
Q4
$224K Buy
+776
New +$211K 0.06% 215
2023
Q3
Sell
-1,015
Closed -$225K 238
2023
Q2
$225K Buy
+1,015
New +$236K 0.06% 208
2020
Q1
Sell
-856
Closed -$206K 219
2019
Q4
$206K Buy
+856
New +$189K 0.06% 284

Other funds holding AMGN

SkyOak Wealth's AMGN Position: Q2 2026 in Review

SkyOak Wealth held its Amgen (AMGN) position steady in Q2 2026 at 764 shares worth $277K. The position accounts for 0.05% of the portfolio, ranked #195.

SkyOak Wealth first reported a position in AMGN in Q4 2019 and has held it in 13 quarters since. The position peaked at $333K in Q4 2024. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • SkyOak Wealth held 764 shares of Amgen worth $277K as of Q2 2026.
  • SkyOak Wealth left its Amgen share count unchanged in Q2 2026.
  • Amgen made up 0.05% of SkyOak Wealth's portfolio in Q2 2026, its #195 holding.
  • SkyOak Wealth first reported a position in Amgen in Q4 2019 and has held it in 13 quarters since.
  • SkyOak Wealth's Amgen position peaked at $333K in Q4 2024.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on SkyOak Wealth's 13F filing for Q2 2026, filed 30 Jul 2026.